Synthetic biology concept stocks opened and fell, and Xinghu Technology hit a fall. Lukang Pharmaceutical, Shuangta Foods, and Weilan Biotech fell by more than 5%, while Fujilai, Hualu Biotech, Yiduoli, and Ruifeng High Materials followed suit.
Synthetic biology concept stocks opened and fell, and Xinghu Technology hit a fall. Lukang Pharmaceutical, Shuangta Foods, and Weilan Biotech fell by more than 5%, while Fujilai, Hualu Biotech, Yiduoli, and Ruifeng High Materials followed suit.
Ruifeng High Materials (300243.SZ): The new energy battery binder business is in the early stages of business development and marketing
Gelonghui, May 13 | Ruifeng High Materials (300243.SZ) said on the investor interactive platform that the new energy battery binder business is in the early stages of business development and marketing, and has not established a supply relationship with it until now.
Ruifeng Hi-Tech: No downward revision of the “Ruifeng Convertible Bonds” conversion price
Shandong Ruifeng Polymer Materials Co., Ltd. announced that the company held the 18th meeting of the 5th board of directors on May 10, 2024 to review and pass the “Proposal on Not to Lower Revise the “Ruifeng Convertible Bonds” conversion price. The board of directors of the company decided not to revise the “Ruifeng Bonds” conversion price downward this time, and within the next six months (that is, May 11, 2024 to November 10, 2024), if it triggers the “Ruifeng Bonds” conversion price downward once again, and does not propose a downward revision plan.
Express News | Ruifeng High Materials: Sales revenue of black phosphorus products is expected to not exceed 500,000 yuan this year, and sales revenue of synthetic biomaterial-related products will not exceed 1 million yuan
Ruifeng Hi-Tech: Currently, the subsidiary Ruifeng Biotech has no plans to invest in large-scale production lines for products related to synthetic biomaterials
Gelonghui, May 8 | Ruifeng High Materials announced that in March 2023, the company invested in the establishment of a wholly-owned subsidiary, Shandong Ruifeng Biomaterials Co., Ltd., to lay out the synthetic biomaterials industry. At present, Ruifeng Biotech has completed pilot testing of products such as one-step polylactic acid (a bio-based degradable material), bio-succinic acid (a raw material for biodegradable PBS, and food and drug additives, etc.), and dextran (a raw material for bio-based iron supplements). Dextran products are being prepared for marketing (due to current limited market demand for dextrose anhydride, Ruifeng Biotech is marketing through pilot production line products.
Express News | Ruifeng High Materials: The technical barriers to the industrialization of black phosphorus are high, and there is great uncertainty
Express News | Ruifeng High Materials: In March 2023, the company invested in the establishment of a wholly-owned subsidiary Ruifeng Biotech to lay out the synthetic biomaterials industry. At present, Ruifeng Biotech has completed pilot testing of products such as one-s
Dragon Tiger List | The concept of synthetic biology is hot, and tourist groups are pouring in! Lukang Pharmaceutical is popular among Fang Xinxia and the Yushin Clan
The top three net purchases on the Dragon Tiger list today are Rhine Biotech, Ruifeng Hi-Tech, and Lukang Pharmaceutical
Synthetic biology concept stocks continued to rise in the afternoon, with Kyodo Pharmaceutical rising and falling 20 cm. Various stocks such as Blue Biotech, Ruifeng Hi-Tech, Lukang Pharmaceutical, Xinghu Technology, Qianjiang Biochemical, and Rhine Biote
Synthetic biology concept stocks continued to rise in the afternoon, with Kyodo Pharmaceutical rising and falling 20 cm. Various stocks such as Blue Biotech, Ruifeng Hi-Tech, Lukang Pharmaceutical, Xinghu Technology, Qianjiang Biochemical, and Rhine Biotech closed. Yiqiao Shenzhou and Tuoxin Pharmaceutical surged more than 14%.
Express News | The synthetic biology concept rebounded and Ruifeng High Materials rose more than 15%
Ruifeng High Materials (300243.SZ): Net profit of 9.7775 million yuan in the first quarter decreased by 44.71% year-on-year
Gelonghui, April 26 | Ruifeng Hi-Tech (300243.SZ) released its report for the first quarter of 2024. Operating revenue for the reporting period was 488 million yuan, up 18.81% year on year; net profit attributable to shareholders of listed companies was 9.7775 million yuan, down 44.71% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 9.1757 million yuan, down 47.00% year on year; basic earnings per share were 0.04 yuan.
Ruifeng High Materials (300243): Main business is stable, and there is plenty of room for growth in performance
Incident: The company released its 2023 report, achieving total operating revenue of 1,776 million yuan, a year-on-year decrease of 3.04%; net profit to mother of 85 million yuan, +39.51% year-on-year. Prices of raw materials fell, and the company's profit increased year-on-year
Ruifeng High Materials (300243.SZ) reported 2023 annual results, net profit of 85,294,800 yuan, an increase of 39.51% year-on-year
Ruifeng High Materials (300243.SZ) released its 2023 annual report, with operating revenue of 1,776 billion yuan, compared with...
Ruifeng Hi-Tech (300243.SZ): Net cash flow from operating activities is at a normal and reasonable level
Gelonghui, March 12 | Ruifeng Hi-Tech (300243.SZ) said on the investor interactive platform that due to some downstream customers of the company using bank draft payment methods and the gradual expansion of the company's business scale in recent years, the cash flow of products sold was less than the operating income of that year. The net cash flow from the company's operating activities is at a normal and reasonable level.
Ruifeng Hi-Tech (300243.SZ): As of February 29, 2024, the total number of shareholders of the company was 1,6037
Gelonghui March 12 | Ruifeng Hi-Tech (300243.SZ) said on the investor interactive platform that as of February 29, 2024, the total number of shareholders of the company was 1,6037.
Ruifeng High Materials (300243.SZ): Currently, the main business/products are general-purpose plastic PVC additives, engineering plastic additives and degradable materials
Gelonghui March 12 | Ruifeng High Materials (300243.SZ) said on the investor interactive platform that the company's main business/products are general plastic PVC additives, engineering plastic additives and degradable materials.
Express News | Ruifeng Hi-Tech: Expected profit of 830 million yuan to 930 million yuan in 2023, an increase of 35.76%-52.11%
Zhou Shibin, the actual controller of Ruifeng Hi-Tech (300243.SZ), pledged 16.76 million shares
Ruifeng Hi-Tech (300243.SZ) announced that part of the company owned by Zhou Shibin, the controlling shareholder and actual controller of the company...
Ruifeng Hi-Tech (300243.SZ)'s fixed stock increase was approved for registration by the China Securities Regulatory Commission
Ruifeng Hi-Tech (300243.SZ) issued an announcement. The company recently received the China Securities Regulatory Commission (“China...
Ruifeng High Materials (300243.SZ): Net profit for the first three quarters was 66.038 million yuan, up 11.98% year on year
On October 27, Gelonghui Hi-Tech (300243.SZ) announced its third quarter report. Operating income was 1,317 billion yuan, down 3.06% year on year, net profit was 66.038 million yuan, up 11.98% year on year, net profit was 66.038 million yuan, net profit was up 11.98% year on year, net profit was 64.21 million yuan, up 23.89% year on year, and basic earnings per share of 0.28 yuan.
No Data